Roles and mechanisms of tumour-infiltrating B cells in human cancer: a new force in immunotherapy

Abstract Immune checkpoint inhibitors (ICIs) targeting PD-1 or PD-L1 have emerged as a revolutionary treatment strategy for human cancer patients. However, as the response rate to ICI therapy varies widely among different types of tumours, we are beginning to gain insight into the mechanisms as well...

Full description

Bibliographic Details
Main Authors: Enkui Zhang, Chengsheng Ding, Shuchun Li, Xueliang Zhou, Batuer Aikemu, Xiaodong Fan, Jing Sun, Minhua Zheng, Xiao Yang
Format: Article
Language:English
Published: BMC 2023-03-01
Series:Biomarker Research
Subjects:
Online Access:https://doi.org/10.1186/s40364-023-00460-1